R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Vice President - Global Environmental Health & Safety

Environmental Health & SafetyConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA

About the Job

Requirements

  • A BS/BA degree in Environmental Health & Safety, industrial hygiene, occupational safety, environmental science, engineering, life sciences, or a related discipline is required.
  • At least 18 years of progressively responsible EHS experience, including significant executive-level leadership in the global pharmaceutical industry.
  • Demonstrated experience leading EHS for a multinational pharmaceutical company with operations across multiple countries and regions, with direct accountability for global strategy, governance, regulatory compliance, audit and assurance, incident management, and executive reporting.
  • At least 10 years of people-leadership experience, including building, scaling, and leading global or regional EHS teams across a complex, matrixed organization.
  • Demonstrated experience supporting a broad pharmaceutical operating model, including research laboratories, clinical development, technical operations, external manufacturing, supply chain, corporate offices, and commercial or medical field organizations.
  • Demonstrated experience opening and integrating international offices or facilities, establishing EHS programs in new countries, and translating enterprise standards into locally compliant requirements.
  • Demonstrated experience managing EHS for a worldwide, mobile, and field-based workforce, including global sales, medical affairs, market access, or comparable commercial organizations.
  • Deep knowledge of U.S. EHS requirements, including OSHA, EPA, and Cal/OSHA, and strong working knowledge of international EHS regulatory frameworks and compliance governance through regional leaders and local subject-matter experts.
  • Demonstrated leadership of ESG or corporate sustainability programs within a global pharmaceutical or similarly regulated life-sciences company, including strategy development, governance, metrics, target setting, disclosure, data controls, and executive or Board reporting.
  • Ability to communicate complex risk, regulatory, and operational issues clearly to the Board, senior executives, employees, regulators, investors, and external partners.
  • Strong business judgment and change-management capability, with success prioritizing risk and investment in a fast-paced, high-growth, science-driven organization.
  • Ability and willingness to travel domestically and internationally.

Responsibilities

  • Define the enterprise EHS vision, multi-year roadmap, policies, standards, and operating model aligned with pipeline advancement, clinical development, commercialization, product launch, and international growth.
  • Lead EHS due diligence, site-selection coordination, design reviews, permitting, pre-occupancy readiness, emergency planning, and operational launch support for new offices and facilities worldwide; establish repeatable global expansion playbooks.
  • Develop scalable EHS programs for the worldwide workforce, including field sales, medical affairs, market access, remote and hybrid employees, frequent travelers, and employees working in healthcare, customer, conference, and third-party environments.
  • Establish duty-of-care expectations for travel, lone work, driving, ergonomics, emergency response, and country-specific occupational health requirements.
  • Integrate EHS risk into enterprise risk management, business planning, capital allocation, business continuity, crisis management, insurance, and executive decision-making.
  • Maintain a risk-based global compliance framework addressing occupational safety, environmental protection, fire and life safety, hazardous materials and waste, biosafety, transportation, contractor safety, and occupational health; translate global standards into locally compliant programs and support them with audits, assurance, and management reviews.
  • Advise executive leadership and the Board on material risks, emerging regulatory trends, performance, crisis response, and investment priorities; build a prevention-first culture focused on predictive risk management and operational excellence.
  • Build, lead, and develop a global EHS organization and regional network of employees, site leaders, consultants, and service providers; establish decision rights, accountabilities, succession plans, and capability-development programs.
  • Establish enterprise metrics, dashboards, management reviews, audit protocols, corrective-action governance, and executive reporting; benchmark performance across sites and regions and use leading indicators, trend analysis, and risk intelligence to identify systemic issues and drive continuous improvement.
  • Ensure timely escalation, investigation, root-cause analysis, corrective action, and organizational learning for incidents and near misses worldwide; provide executive leadership during significant EHS events, regulatory inspections, public-health events, and business disruptions.
  • Provide strategic oversight for laboratory, office, and technical-operations safety programs, including chemical and biological safety, industrial hygiene, process and equipment safety, hazardous materials and waste, electrical safety, lockout/tagout, hot work, contractor safety, ergonomics, occupational health, indoor environmental quality, and emergency response.
  • Own the integrity and governance of EHS- and sustainability-related ESG data, including definitions, methodologies, internal controls, source documentation, validation, and executive certification.
  • Lead preparation of relevant content for corporate responsibility reports, investor and customer questionnaires, ratings and benchmarking submissions, and required or voluntary disclosures; coordinate readiness for internal audit and independent assurance.
  • Develop a risk-based roadmap for greenhouse-gas emissions, energy, water, waste, hazardous materials, climate resilience, and responsible resource use across owned and leased locations and the pharmaceutical value chain.
  • Establish credible baselines, targets, and performance plans, including Scope 1 and 2 emissions and, as appropriate, material Scope 3 categories involving suppliers, CDMOs, CROs, logistics providers, business travel, and other partners.

Desired Qualifications

  • An MA/MS, MBA, or other relevant advanced degree.
  • Professional certification such as CSP, CIH, CHMM, or an equivalent international credential.
  • Experience implementing and sustaining global EHS management systems aligned with standards such as ISO 45001 and ISO 14001.
  • Experience engaging with global regulators, works councils, occupational-health providers, insurers, and external assurance partners.
  • Working knowledge of ESG and sustainability frameworks and disclosure regimes relevant to multinational companies, including the GHG Protocol, ISSB/IFRS S1 and S2, TCFD-aligned climate disclosure, CDP, GRI, SASB industry standards, and applicable U.S. and international climate- and sustainability-reporting requirements.
  • Experience developing greenhouse-gas inventories and reduction roadmaps, evaluating Scope 3 emissions, engaging suppliers and external manufacturing partners, and preparing ESG information for third-party assurance, investor review, or public reporting.
  • Multilingual capability.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs